Adverse Health Events Associated with Antimicrobial Drug Resistance inCampylobacterSpecies: A Registry‐Based Cohort Study | Zendy

Morten Helms | Zendy; Jacob Simonsen | Zendy; Katharina E. P. Olsen | Zendy; Kåre Mølbak | Zendy

Open Access

Adverse Health Events Associated with Antimicrobial Drug Resistance inCampylobacterSpecies: A Registry‐Based Cohort Study

Author(s) -

Morten Helms,

Jacob Simonsen,

Katharina E. P. Olsen,

Kåre Mølbak

Publication year - 2005

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/428453

Subject(s) - campylobacter , medicine , odds ratio , adverse effect , erythromycin , antibiotic resistance , quinolone , cohort , cohort study , drug resistance , intensive care medicine , microbiology and biotechnology , antibiotics , biology , bacteria , genetics

Resistance to clinically important antimicrobial agents, particularly fluoroquinolones and macrolides, is increasing among Campylobacter isolates, but few studies have explored the human health consequences of such resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research